Hybrid PCR Advantage Leverage Clarity Lab Solutions unique hybrid PCR and culture workflow to offer customers faster, accurate pathogen identification with resistance gene detection and viability confirmation, appealing to hospitals and clinics seeking precise diagnostics and improved treatment decisions.

Rapid Results Upsell Position 24- to 48-hour one-page results as a differentiator for time-sensitive settings such as urgent care, emergency departments, and post-surgical care pathways, creating opportunities to replace slower traditional methods and capture higher-value testing mix.

Versatile Coverage Target expanding markets for UTI, wound, ENT, respiratory and COVID testing, emphasizing comprehensive solutions under one lab to simplify vendor management, reduce turnaround times, and consolidate testing spend for medium-sized hospitals and multi-site clinics.

In Vivo Simulation Promote the pooled antibiotic sensitivity testing in a polymicrobial in vivo-like environment as a novel value prop to pharmaceutical and hospital systems concerned with multi- organism resistance patterns, opening conversations with stewardship programs and formulary committees.

Support and Accessibility Highlight dedicated small-lab premium support, Medicare/Medicaid coverage, and no cost shipping and supplies to attract cost-conscious regional labs and community hospitals looking for reliable, affordable diagnostic partners with favorable economics.